The Society For Rna Therapeutics

What The Society For Rna Therapeutics does

The Society for RNA Therapeutics (SRT) is a US-based, non-profit professional membership organization headquartered in Washington, DC, and led by President John P. Cooke, M.D., Ph.D. (Houston Methodist Research Institute). Its mission is to advance RNA therapeutics research, education, and translational progress by serving as the convening body for the global RNA community across academia, industry, and clinical practice, spanning modalities including mRNA, siRNA, saRNA, circRNA, miRNA, antisense, and aptamers. The organization is governed by a Board of Directors that includes 2023 Nobel Laureate Drew Weissman (University of Pennsylvania) and senior researchers from Johns Hopkins, Yale, Duke, Baylor, Cold Spring Harbor Laboratory, City of Hope, University of Michigan, UBC, Tel Aviv University, and Boston Children's Hospital / Harvard Medical School.

SRT's core offerings consist of two membership tiers (Professional at $300/year and Trainee at $170/year), an Annual Meeting, the recurring Expert Talk Series webinar program (co-developed with the Canadian RNA Biomanufacturing Co-op and supported by BioCanRx), joint scientific programming with the Alliance for mRNA Medicines at ASCENT 2026 (October 28–30, 2026, Coronado, CA), Young Investigator Awards and trainee programming, and shared standards, position papers, and regulatory frameworks developed through four standing committees (Governance, Outreach, Communications, Education). The society does not develop proprietary technology products and operates without an API or software product surface.

Commercially, SRT generates revenue from recurring annual membership dues and event registration fees, distributes services via self-serve membership enrollment (JotForm) and direct event registration on its website, and reaches its audience through X (@RNA_Therapeutic), LinkedIn, the srnat.org website, email newsletters, press releases, and earned media (including New York Times essays by board members). In June 2026 the society appointed its first Executive Director, Luke Thorstenson (MBA), and Secretary Andrew Varley, Ph.D., and outlined a 24-month strategic agenda emphasizing education, convening, guidelines development, trainee investment, advocacy, and international expansion beyond the US-centric base into Europe and Asia Pacific.

Name

The Society For Rna Therapeutics

Legal name

The Society for RNA Therapeutics

Website

https://srnat.org

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

The Society for RNA Therapeutics (SRT) is a US-based non-profit professional membership society that convenes RNA therapeutics researchers, clinicians, trainees, and industry scientists globally, offering $300/$170 annual memberships, an annual meeting, the Expert Talk Series, joint ASCENT 2026 programming with AMM, and standards-setting committees.

Ownership category

akta.pro rank

Product category

Professional Membership Services

NAICS

Professional Organizations (81392), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Membership Organizations (8600), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

RNA Therapeutics Platforms & Design (sequence design, target ID/validation, AI/bioinformatics) (HLAAADAG)

akta.pro secondary industries

RNA Therapeutics Regulatory, Quality & Pharmacovigilance (GxP, comparability, post-market) (HLAAADAJ), RNA Therapeutics Clinical Development (trial design, endpoints, patient stratification) (HLAAADAH)

Keywords

• Professional membership society
• RNA therapeutics research
• Clinical trial guidelines
• Annual scientific meeting
• Biomanufacturing standards

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Professional Membership Dues: Annual membership fee of $300/year for scientists, clinicians, and industry professionals working in RNA therapeutics. Provides access to global network, event registration discounts, committee participation, and voice in RNA manufacturing standards and clinical guidelines.
2. Trainee Membership Dues: Annual membership fee of $170/year for graduate students, postdoctoral fellows, and clinical fellows. Includes all professional member benefits plus trainee-specific Young Investigator Awards and programming.
3. Event Registration Fees: Revenue generated from registration fees for SRT events including the Annual Meeting and ASCENT 2026 conference.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

The Society for RNA Therapeutics is a non-profit professional membership organization offering annual Professional ($300/year) and Trainee ($170/year) memberships that grant access to a global network of RNA therapeutics scientists, clinicians, and industry professionals. It convenes the field through an Annual Meeting, the ASCENT joint scientific conference with the Alliance for mRNA Medicines, and a monthly Expert Talk Series webinar program, while developing RNA manufacturing standards, clinical trial guidelines, and clinical best practices and supporting early-career researchers through Young Investigator Awards and programming.

Product overview

The Society for RNA Therapeutics (SRT) is a professional membership organization offering a portfolio of membership tiers (Professional at $300/year and Trainee at $170/year), annual convenings (SRT Annual Meeting, ASCENT joint programming), educational programming (SRT Expert Talk Series), professional development initiatives (Young Investigator Awards), and standards development through four standing committees (Governance, Outreach, Communications, Education). These offerings work together to advance RNA therapeutics research, education, and innovation while providing networking and career development opportunities for the global RNA therapeutics community.

Differentiator

Problem solved

Functional benefit

Products and services

• Professional Membership Annual membership for scientists, clinicians, and industry professionals working in RNA therapeutics at $300/year, providing access to the global SRT professional network, event registration discounts, committee participation, and voice in RNA manufacturing standards and clinical guidelines.
• Trainee Membership Annual membership for graduate students, postdoctoral fellows, and clinical fellows at $170/year, including all Professional member benefits plus trainee-specific Young Investigator Awards, programming, and direct access to industry leaders.
• SRT Annual Meeting Flagship annual convening for RNA therapeutics researchers, clinicians, trainees, and industry scientists to exchange ideas and shape the field. For 2026, the dedicated scientific programming moves to ASCENT; members also gather separately on October 27, 2026 to discuss society business.
• ASCENT 2026 Annual Meeting (Joint Programming with Alliance for mRNA Medicines) Joint scientific programming with the Alliance for mRNA Medicines featuring dedicated sessions on translational and innovative RNA therapeutics, keynote discussions, panel sessions, one-on-one partnering opportunities, and a new poster session for academic researchers and industry, scheduled October 28-30, 2026 in Coronado, California.
• SRT Expert Talk Series Monthly seminar series bringing together researchers, clinicians, trainees, and industry professionals for conversations on the science, practice, and future of RNA therapeutics. Sessions are recorded and available on demand; developed in partnership with leading RNA research organizations including the Canadian RNA Biomanufacturing Co-op and BioCanRx.
• Position Papers and Guidelines Shared standards, position papers, and regulatory frameworks covering RNA manufacturing, clinical trial design, and clinical best practices developed by the SRT Communications Committee.
• Young Investigator Awards and Programming Awards and programming designed to support early-career RNA researchers, including trainee-specific discounts on membership and events, direct access to industry leaders, and pathways between academic training and careers in RNA therapeutics industry.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered flagship, core and supporting.

• Alliance for mRNA Medicines (AMM)flagshipStrategic or Co-development Partner · 17 June 2026SRT and AMM partnered to jointly present ASCENT 2026, AMM's flagship annual meeting taking place October 28-30, 2026 in Coronado, California. Together they are developing dedicated scientific sessions on translational and innovative RNA therapeutics and launching a new poster session for academic researchers and industry. The collaboration combines AMM's convening power across the mRNA industry with SRT's RNA research expertise.
• Canadian RNA Biomanufacturing Co-opcoreStrategic or Co-development PartnerPartnership in developing the SRT Expert Talk Series. The Canadian RNA Biomanufacturing Co-op is a co-development partner in creating sessions that bring together researchers, clinicians, trainees, and industry professionals for conversations on RNA therapeutics science and practice.
• BioCanRxsupportingStrategic or Co-development PartnerProvides support for the SRT Expert Talk Series, contributing to the advancement of RNA therapeutics knowledge exchange and professional development programming.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Biotechnology Innovation Organization (BIO): The largest US biotech trade association with much broader remit (drugs, ag, industrial) but overlapping industry-sponsor pool; competes for corporate membership dollars from RNA therapeutic companies.
• PhRMA: Largest US pharmaceutical industry trade association with established advocacy and regulatory partnership infrastructure relevant to RNA therapeutic companies; broader scope but competing for industry sponsor relationships.
• Drug Information Association (DIA): Global life-sciences professional association covering drug development, regulatory, and clinical topics; competes with SRT for industry sponsors and hosts overlapping regulatory-focused programming.
• American Association of Pharmaceutical Scientists (AAPS): US-based pharmaceutical scientific society serving industry and academia with annual meetings, journals, and member tiers; serves an overlapping bench-scientist audience with broader drug-delivery and manufacturing remit.
• International Society for Pharmaceutical Engineering (ISPE): Global not-for-profit serving pharmaceutical manufacturing professionals with strong manufacturing-standards focus; adjacent to SRT's biomanufacturing/CMC standards work and competing for industry-side sponsorship.
• American Society for Biochemistry and Molecular Biology (ASBMB): Major US scientific society serving molecular biology researchers with journals, meetings, and advocacy; serves a portion of the academic RNA-research audience and competes for trainee membership and meeting participation.

Direct peers

• Alliance for Regenerative Medicine (ARM): Global convening body for the cell and gene therapy sector with similar membership, sponsorship, and advocacy model; SRT's Executive Director (Thorstenson) was an ARM founding-team member, making it the closest operational precedent.
• American Society of Gene & Cell Therapy (ASGCT): Largest US professional society covering gene and cell therapy research with overlapping academic, trainee, and industry audiences; competes with SRT for RNA therapeutics researchers, particularly around clinical guidelines and standards work.
• International Society for Stem Cell Research (ISSCR): International scientific society convening researchers around a translational therapeutic modality; comparable operating model of membership tiers, annual meeting, guidelines, and trainee programs applied to an adjacent biotech field.
• Alliance for mRNA Medicines (AMM): Industry trade association focused on mRNA medicines and a direct strategic partner to SRT; both convene the RNA therapeutics community and co-present ASCENT 2026. Highly comparable in mission and audience.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/RNA_Therapeutic
• LinkedInlinkedin.com/company/the-society-for-rna-therapeutics

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Society For Rna Therapeutics